On Air Now

Listen

Listen Live Now » 95.5 FM Wausau, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
66° Feels Like: 66°
Wind: SW 10 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 44°

Tomorrow

Sunny 72°

Tues Night

Partly Cloudy 47°

Alerts

Breaking News

BREAKING NEWS / UPDATE: Wausau police confirm Stephanie Low's body was found in Wabeno; person of interest Kristopher Torgerson to be charged with homicide

WAUSAU, Wis (WSAU)  Wausau police say Stephanie Low's body has been found. Police revealed at a news conference today that a person of interest in her death, Kristopher Torgerson, led police to her body on September 19th. The body has since been positively ID'ed by the state crime lab. The autopsy lists 'homicide' as the cause of death. Torgerson had been questioned nearly four years ago after she had first disappeared. Wausau PD say he was in custody on other charges, and agreed to sh...

Read More »

J&J says halting development of Botox rival

(Reuters) - Johnson & Johnson said on Friday it was ending its efforts to bring to market a rival drug to Allergan Inc's popular Botox anti-wrinkle treatment.

J&J had acquired the drug, PurTox, with its 2009 purchase of Mentor, a leading maker of breast implants for cosmetic augmentation and reconstructive surgery.

"After careful consideration, our Mentor business has decided to discontinue its neurotoxin program, commonly known as PurTox, in order to focus on its core breast surgery business, where we are an established leader and see greater opportunities to benefit patients and grow our business," J&J spokesman Thomas Sanford said in an emailed statement.

Ending the PurTox development program will result in the elimination of a small number of jobs in the United States, the company said.

Botox is Allergan's biggest selling product with annual sales of more than $2 billion and little serious competition.

The drug is primarily used cosmetically via injections to erase wrinkles on the forehead. It has also been approved for several medical uses such as to treat overactive bladder, migraine headaches, upper limb spasticity and severe underarm sweating.

J&J declined to say whether it would take a charge associated with halting the anti-wrinkle drug development. The company is expected to report first quarter financial results next week.

(Reporting by Bill Berkrot)

Comments